Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial.
Kopetz S, Yoshino T, Van Cutsem E, Eng C, Kim TW, Wasan HS, Desai J, Ciardiello F, Yaeger R, Maughan TS, Beyzarov E, Zhang X, Ferrier G, Zhang X, Tabernero J.
Kopetz S, et al. Among authors: zhang x.
Nat Med. 2025 Jan 25. doi: 10.1038/s41591-024-03443-3. Online ahead of print.
Nat Med. 2025.
PMID: 39863775